Pacific Global Holdings plc (AIM: PCH), an AIM quoted investing company, announces its half-yearly result for the six months to 31 July 2025.
OMEGA FLEX, INC. (OFLX) Nine Months Ended September 30, Three Months Ended September 30, 2025 2024 2025 2024 Net Sales $73,089 ...
Net Income per Diluted Share of $0.07 for the Quarter, inclusive of Income from Discontinued Operations Core FFO per Share of $2.28 for the Quarter ...
Q3 2025 Net Revenue of $785 million; GAAP Net Income of $2 million; Diluted Income per Share of $0.01 ?? Adjusted EBITDA of $160 million; Adjusted Diluted EPS of $0.17 ?? Updated 2025 Full Year Guidan ...
KALMAR CORPORATION, INTERIM REPORT JANUARY-SEPTEMBER 2025, 31 OCTOBER 2025 AT 9:00 AM (EET) Kalmar's interim report January-September 2025: Improved profitability in the quarter Record-high comparable ...
LONDON, UK / ACCESS Newswire / October 31, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), an emerging leader in the field of longevity research, focused on develo ...
Marimekko Corporation, Interim Report, 31 October 2025 at 8.00 a.m. EET INTERIM REPORT OF MARIMEKKO CORPORATION, 1 January-30 September 2025: Marimekko's net sales and operating profit increased in ...
Press release31 October 2025 - N° 18 Third quarter 2025 results EUR 217 million net income in Q3 2025, contributing to a strong nine-month net income of EUR 642 million Group ...
Daito Trust Construction Co., Ltd. (DIFTY) on Friday reported a decline in profit for the six months ended September 30, 2025, despite growth in sales.Profit before income taxes ...
Hawkins, Inc. (Nasdaq: HWKN) today announced results for the six months ended September 28, 2025, its second quarter of fiscal 2026. Second Quarter ...
Fanapt® Q3 2025 net product sales increased by 31% to $31.2 million compared to Q3 2024 BysantiTM (milsaperidone) NDA for bipolar I disorder and schizophrenia ...
Dose-dependent mean reductions of Activin E of up to 85% one month post single dose of WVE-007 in INLIGHT clinical trial, exceeding levels that led to weight loss in preclinical models; WVE-007 is gen ...